Table 3. Patient characteristics of group A (liver resection after radioembolization), group B (liver surgery) and group C (radioembolization); mean values are displayed.
| Variable | Group A | Group B | Group C | P value |
|---|---|---|---|---|
| Mean age (years) | 60.7 (53.8–75) | 58.4 (32.7–87.5) | 65.3 (52.3–72.6) | N/S |
| Mean postoperative hospital stay (days) | 15.3 [10–26] | 17.5 [7–49] | N/A | N/S |
| Mean Ki-67 index primary tumor | 5.9% (1–20%) | 6.1% (1–20%) | 6.9% (2–10%) | N/S |
| Mean Ki-67 index liver metastasis | 11.4% (2–50%) | 9.7% (1–30%) | 8.7% (2–15%) | N/S |
| Mean hepatic tumor load | 31.4% (1–60%) | 25.8% (1–80%) | 30% (5–85%) | N/S |
| Mean RE dose (MBq) | 1,746 [1,310–2,200] | N/A | 1,483 [583–2,249] | N/S |
| Mean ASA score | 2.8 [2–3] | 3 | N/A | N/S |
| Mean MELD score | 7.4 [6–12] | 7.7 [6–13] | 7.2 [6–11] | N/S |
| Mean blood loss (mL) | 1,066.3 [100–2,200] | 1,274.3 [300–3,000] | N/A | N/S |
| Mean duration of operation (min) | 206.9 [110–363] | 230.7 [108–564] | N/A | N/S |
| Severe complications | 25% | 29.4% | N/A | N/S |
ASA, American Society of Anesthesiologists; MELD, Model of End Stage Liver Disease; min, minutes; mL, milliliter; N/A, not applicable; N/S, not significant.